Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that three sessions of injectable platelet-rich fibrin (i-PRF+) significantly improved hair follicle density, hair volume, and thickness, as well as patient satisfaction in women with female pattern hair loss, with only minor self-limited adverse effects reported.

This study found that low ferritin levels are associated with higher telogen ratios in women with diffuse hair loss, suggesting an important role of ferritin in telogen effluvium diagnosis.

This study found that platelet-rich plasma therapy may be a useful alternative to 5% topical minoxidil for treating androgenetic alopecia, with differences in the effectiveness and patient satisfaction outcomes observed.

This paper describes androgenic alopecia as a hereditary form of hair loss influenced by androgens, outlining its diagnosis, treatment options like minoxidil and finasteride, and the importance of psychological support due to its impact on quality of life.

This review discusses the pathophysiology of alopecia areata, highlighting the role of CD8 cytotoxic T cells and the upregulation of JAK signaling pathways; it reports no new experimental results.

This study observed that patients who received Favipiravir treatment after having COVID-19 had lower positive pull test scores for telogen effluvium hair loss compared to those who did not, suggesting that Favipiravir may not influence the development of telogen effluvium.

This review article reports recent advancements in understanding, diagnosing, and treating various hair loss conditions, like androgenetic alopecia and alopecia areata, including their genetic factors and new therapeutic options, while also examining the impact of COVID-19 on hair loss.

This article reviews drug-induced alopecia, its diagnosis, and treatments, but presents no new clinical findings.

This article presents cases of two patients experiencing excessive hair shedding 2 to 3 months after COVID-19 infection, highlighting a possible link to telogen effluvium.

The shampoo helps reduce hair loss and improves Minoxidil® absorption.

In this study, acupuncture therapy targeting specific points significantly reduced hair loss in women aged 31-50 with androgenic alopecia.

This study found that low dose methotrexate did not increase hair loss in rheumatoid arthritis patients compared to healthy controls, and many patients even showed a reduction in hair fall over the short term.

This paper discusses alopecia areata, its autoimmune nature, factors influencing susceptibility, diagnostic challenges, and treatment limitations, concluding that no current therapy is curative or preventive; it reports no new clinical results.

This study found that non-scarring acquired alopecias were the most common hair and scalp diseases among children visiting a pediatric dermatology outpatient clinic.

A woman's hair grew back after she stopped taking the Parkinson's disease medication pramipexole.

This study found that combining PRP with microneedling was more effective than PRP alone in improving hair growth and patient perception of hair loss in androgenetic alopecia up to Hamilton-Norwood grade 4.

This study observed that while platelet-rich plasma showed positive short-term effects on hair density in individuals with androgenic alopecia, its effectiveness declined after four months, suggesting possible need for additional treatment.

In this study, all androgenetic alopecia patients treated with six sessions of platelet-rich plasma over six months experienced increased hair density and improved hair pull tests, suggesting PRP as an effective and safe treatment option.

This study found that autologous platelet-rich plasma treatment significantly increased the number of hairs in male patients with androgenetic alopecia.

In this study involving 20 patients with androgenic alopecia, monthly platelet-rich plasma injections over six months significantly improved hair loss, increasing the average hair follicular units from 60 to 84 and resulting in negative hair pull tests for 17 patients.

In this prospective study, combining 5% topical minoxidil with platelet rich plasma provided more significant improvements in hair parameters for male baldness than platelet rich plasma alone over six months.

This study found that oral finasteride is safe, well tolerated, and effective in improving hair growth in men with androgenetic alopecia, with noticeable benefits seen as early as three months into treatment.

This article reviews various causes and investigative techniques for different forms of alopecia and reports no new findings.

This case report describes a 37-year-old woman whose recurrent hair shedding was associated with low iron stores and a miscarriage, with improvements seen after increased iron intake.

This review outlines a systematic approach for dermatologists to accurately diagnose hair loss disorders, emphasizing the importance of differentiating between scarring and non-scarring alopecia to guide appropriate treatment decisions.

This article reviews various causes of diffuse hair loss, highlighting the importance of identifying triggers through thorough examination for effective treatment and emphasizing patient education in management; it reports no new clinical findings.

This review discusses telogen effluvium, a common type of hair loss, focusing on differentiation from other conditions and potential causes, but presents no new research findings.

This study found that loose anagen hair syndrome is a common form of alopecia in young girls, typically presenting with thin, sparse hair and usually confirmed by a hair-pull test.

This study concluded that platelet-rich plasma injections significantly improved hair density, thickness, and scalp inflammation in both male and female pattern hair loss, with better outcomes in lower-grade cases.

This article discusses the causes, diagnosis, and treatment options for female pattern hair loss, emphasizing the role of topical minoxidil as a primary treatment, but provides no new clinical results.